Product Information
CEFEPIME HCL 1 GM VIAL is a generic product labeled by Sagent Pharmaceuticals, priced at $3.7308 per EA under NDC 25021012120. Its NADAC has been published 171 times since Jan 22, 2014.
Strength
1 g/1
Manufacturer
Sagent PharmaceuticalsNDC
25021012120
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
8/20/2025
Active Ingredients
CEFEPIME HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065441On Market Since
5/1/2008
Pharmacological Classes
Price Statistics
The NADAC for CEFEPIME HCL 1 GM VIAL has been published 171 times since Jan 22, 2014, and over the history we have for it it has declined 34.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7308 per EA |
|---|---|
| All-time high | $5.6658 (Feb 11, 2015) |
| All-time low | $3.3241 (Apr 23, 2025) |
| 52-week high | $3.7308 |
| 52-week low | $3.5001 |
| Median price | $3.7308 |
| Average price | $4.3054 |
| Largest weekly change | -36.3% (Apr 17, 2024) |
| Weeks tracked | 171 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the cefepime hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CEFEPIME HCL 1 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFEPIME HCL 1 GM VIAL, manufactured by Sagent Pharmaceuticals, is $3.7308 per EA (NDC 25021012120), effective Jun 24, 2026.
How has the price of CEFEPIME HCL 1 GM VIAL changed over time?
Over the history we have for it, the NADAC for CEFEPIME HCL 1 GM VIAL has declined 34.2%. It has been tracked across 171 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for CEFEPIME HCL 1 GM VIAL?
Since Jan 22, 2014, the NADAC for CEFEPIME HCL 1 GM VIAL has ranged from a low of $3.3241 (Apr 23, 2025) to a high of $5.6658 (Feb 11, 2015), with a median of $3.7308 per EA.
Are there cheaper alternatives to CEFEPIME HCL 1 GM VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CEFEPIME HCL 1 GM VIAL, so no direct lower-cost alternative is listed.
Who manufactures CEFEPIME HCL 1 GM VIAL?
CEFEPIME HCL 1 GM VIAL (NDC 25021012120) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification